205 related articles for article (PubMed ID: 25300947)
1. Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome.
Camilo V; Barros R; Celestino R; Castro P; Vieira J; Teixeira MR; Carneiro F; Pinto-de-Sousa J; David L; Almeida R
BMC Cancer; 2014 Oct; 14():753. PubMed ID: 25300947
[TBL] [Abstract][Full Text] [Related]
2. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes.
Tsukamoto T; Mizoshita T; Mihara M; Tanaka H; Takenaka Y; Yamamura Y; Nakamura S; Ushijima T; Tatematsu M
Histopathology; 2005 Jun; 46(6):649-58. PubMed ID: 15910596
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients.
Ribeirinho-Soares S; Pádua D; Amaral AL; Valentini E; Azevedo D; Marques C; Barros R; Macedo F; Mesquita P; Almeida R
BMC Cancer; 2021 Apr; 21(1):359. PubMed ID: 33823840
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional factor typing with SOX2, HNF4aP1, and CDX2 closely relates to tumor invasion and Epstein-Barr virus status in gastric cancer.
Uozaki H; Barua RR; Minhua S; Ushiku T; Hino R; Shinozaki A; Sakatani T; Fukayama M
Int J Clin Exp Pathol; 2011 Mar; 4(3):230-40. PubMed ID: 21487519
[TBL] [Abstract][Full Text] [Related]
5. Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer.
Zhang X; Tsukamoto T; Mizoshita T; Ban H; Suzuki H; Toyoda T; Tatematsu M
Oncol Rep; 2009 Mar; 21(3):609-13. PubMed ID: 19212618
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of SOX2 and CDX2 Expression in Barrett's Mucosa.
Barros R; Pereira D; Callé C; Camilo V; Cunha AI; David L; Almeida R; Dias-Pereira A; Chaves P
Dis Markers; 2016; 2016():1532791. PubMed ID: 27766003
[TBL] [Abstract][Full Text] [Related]
7. Sox2 expression is maintained while gastric phenotype is completely lost in Cdx2-induced intestinal metaplastic mucosa.
Mutoh H; Sashikawa M; Sugano K
Differentiation; 2011 Feb; 81(2):92-8. PubMed ID: 21036460
[TBL] [Abstract][Full Text] [Related]
8. Differentiation reprogramming in gastric intestinal metaplasia and dysplasia: role of SOX2 and CDX2.
Camilo V; Garrido M; Valente P; Ricardo S; Amaral AL; Barros R; Chaves P; Carneiro F; David L; Almeida R
Histopathology; 2015 Feb; 66(3):343-50. PubMed ID: 25196071
[TBL] [Abstract][Full Text] [Related]
9. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.
Mizoshita T; Tsukamoto T; Nakanishi H; Inada K; Ogasawara N; Joh T; Itoh M; Yamamura Y; Tatematsu M
J Cancer Res Clin Oncol; 2003 Dec; 129(12):727-34. PubMed ID: 14557879
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of CDX1, CDX2 and SOX2 in patients with gastric cancer also affects the non-malignant mucosa.
Bornschein J; Tóth K; Selgrad M; Kuester D; Wex T; Molnár B; Tulassay Z; Malfertheiner P
J Clin Pathol; 2013 Sep; 66(9):819-22. PubMed ID: 23613102
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.
Roessler K; Mönig SP; Schneider PM; Hanisch FG; Landsberg S; Thiele J; Hölscher AH; Dienes HP; Baldus SE
World J Gastroenterol; 2005 Jun; 11(21):3182-8. PubMed ID: 15929165
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori and the BMP pathway regulate CDX2 and SOX2 expression in gastric cells.
Camilo V; Barros R; Sousa S; Magalhães AM; Lopes T; Mário Santos A; Pereira T; Figueiredo C; David L; Almeida R
Carcinogenesis; 2012 Oct; 33(10):1985-92. PubMed ID: 22791809
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of NKX6.3 in the stomach leads to abnormal expression of CDX2 and SOX2 required for gastric-to-intestinal transdifferentiation.
Yoon JH; Choi SS; Kim O; Choi WS; Park YK; Nam SW; Lee JY; Park WS
Mod Pathol; 2016 Feb; 29(2):194-208. PubMed ID: 26743476
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.
Jun SY; Eom DW; Park H; Bae YK; Jang KT; Yu E; Hong SM
Mod Pathol; 2014 Oct; 27(10):1364-74. PubMed ID: 24603585
[TBL] [Abstract][Full Text] [Related]
15. SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer.
Lundberg IV; Edin S; Eklöf V; Öberg Å; Palmqvist R; Wikberg ML
BMC Cancer; 2016 Jul; 16():471. PubMed ID: 27411517
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma].
Xiong ZF; Xiao H; Tan YS
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):442-6. PubMed ID: 21055171
[TBL] [Abstract][Full Text] [Related]
17. CDX2 as a prognostic marker in gastric cancer.
Masood MA; Loya A; Yusuf MA
Acta Gastroenterol Belg; 2016; 79(2):197-200. PubMed ID: 27382937
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori induces gastric mucosal intestinal metaplasia through the inhibition of interleukin-4-mediated HMG box protein Sox2 expression.
Asonuma S; Imatani A; Asano N; Oikawa T; Konishi H; Iijima K; Koike T; Ohara S; Shimosegawa T
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G312-22. PubMed ID: 19520737
[TBL] [Abstract][Full Text] [Related]
19. Disturbed balance between SOX2 and CDX2 in human vitelline duct anomalies and intestinal duplications.
Raghoebir L; Biermann K; Buscop-van Kempen M; Wijnen RM; Tibboel D; Smits R; Rottier RJ
Virchows Arch; 2013 May; 462(5):515-22. PubMed ID: 23568430
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures.
Wang XT; Wei WY; Kong FB; Lian C; Luo W; Xiao Q; Xie YB
J Exp Clin Cancer Res; 2012 Nov; 31(1):98. PubMed ID: 23181722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
